↓ Skip to main content

Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, September 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
3 X users
patent
30 patents
peer_reviews
1 peer review site

Readers on

mendeley
381 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
Published in
Proceedings of the National Academy of Sciences of the United States of America, September 2012
DOI 10.1073/pnas.1210096109
Pubmed ID
Authors
Abstract

Mitochondrial dysfunctions cause numerous human disorders. A platform technology based on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix could be of enormous potential benefit in treating mitochondrial diseases. Here we report a rationally designed mitochondria-targeted polymeric nanoparticle (NP) system and its optimization for efficient delivery of various mitochondria-acting therapeutics by blending a targeted poly(d,l-lactic-co-glycolic acid)-block (PLGA-b)-poly(ethylene glycol) (PEG)-triphenylphosphonium (TPP) polymer (PLGA-b-PEG-TPP) with either nontargeted PLGA-b-PEG-OH or PLGA-COOH. An optimized formulation was identified through in vitro screening of a library of charge- and size-varied NPs, and mitochondrial uptake was studied by qualitative and quantitative investigations of cytosolic and mitochondrial fractions of cells treated with blended NPs composed of PLGA-b-PEG-TPP and a triblock copolymer containing a fluorescent quantum dot, PLGA-b-PEG-QD. The versatility of this platform was demonstrated by studying various mitochondria-acting therapeutics for different applications, including the mitochondria-targeting chemotherapeutics lonidamine and α-tocopheryl succinate for cancer, the mitochondrial antioxidant curcumin for Alzheimer's disease, and the mitochondrial uncoupler 2,4-dinitrophenol for obesity. These biomolecules were loaded into blended NPs with high loading efficiencies. Considering efficacy, the targeted PLGA-b-PEG-TPP NP provides a remarkable improvement in the drug therapeutic index for cancer, Alzheimer's disease, and obesity compared with the nontargeted construct or the therapeutics in their free form. This work represents the potential of a single, programmable NP platform for the diagnosis and targeted delivery of therapeutics for mitochondrial dysfunction-related diseases.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 381 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 7 2%
India 4 1%
United Kingdom 4 1%
Australia 2 <1%
Sweden 1 <1%
Korea, Republic of 1 <1%
Japan 1 <1%
Spain 1 <1%
Germany 1 <1%
Other 2 <1%
Unknown 357 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 90 24%
Researcher 51 13%
Student > Master 38 10%
Student > Bachelor 28 7%
Student > Doctoral Student 16 4%
Other 56 15%
Unknown 102 27%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 61 16%
Chemistry 55 14%
Biochemistry, Genetics and Molecular Biology 43 11%
Medicine and Dentistry 23 6%
Pharmacology, Toxicology and Pharmaceutical Science 23 6%
Other 61 16%
Unknown 115 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2024.
All research outputs
#1,688,985
of 34,358,242 outputs
Outputs from Proceedings of the National Academy of Sciences of the United States of America
#22,030
of 118,924 outputs
Outputs of similar age
#8,965
of 226,408 outputs
Outputs of similar age from Proceedings of the National Academy of Sciences of the United States of America
#172
of 959 outputs
Altmetric has tracked 34,358,242 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 118,924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 959 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.